Bio-Rad Laboratories (BIO) EPS (Basic) Growth (1y) (2010 - 2026)
Bio-Rad Laboratories (BIO) EPS (Basic) Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -18.42% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 14.04% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -11.88% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 95.65% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 8.20% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -30.89% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 92.59% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 51.01% |
| 10 | Bio-Rad Laboratories | 7.70 Bn | 6.13 Bn | 309.40 Mn | -953.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -953.71% |
| Dec 31, 2025 | 203.29% |
| Sep 30, 2025 | -154.34% |
| Jun 30, 2025 | 115.30% |
| Mar 31, 2025 | -82.99% |
| Dec 31, 2024 | -310.45% |
| Sep 30, 2024 | 540.27% |
| Jun 30, 2024 | -92.62% |
| Mar 31, 2024 | 477.68% |
| Dec 31, 2023 | -56.44% |
| Sep 30, 2023 | 166.61% |
| Jun 30, 2023 | -27.50% |
| Mar 31, 2023 | 102.07% |
| Dec 31, 2022 | 153.08% |
| Sep 30, 2022 | -104.16% |
| Jun 30, 2022 | -200.81% |
| Mar 31, 2022 | -442.36% |
| Dec 31, 2021 | -286.78% |
| Sep 30, 2021 | 197.92% |
| Jun 30, 2021 | -5.49% |